F. Marchetti

Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma

A. Gasbarrini, M. Zoli, F. Piscaglia, 2021, Liver Cancer International.

Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment.

A. Gasbarrini, M. Zoli, F. Piscaglia, 2021, European journal of cancer.

Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study

S. Barni, F. Montemurro, V. Rossi, 2016, PloS one.

Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma.

A. Gasbarrini, F. Piscaglia, R. Golfieri, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.

S. Barni, L. Cavanna, F. Puglisi, 2019, Clinical breast cancer.

The predictive and prognostic role of metabolic and volume-based parameters of positron emission tomography/computed tomography as non-invasive dynamic biological markers in early breast cancer treated with preoperative systemic therapy

R. Mazzola, A. Inno, F. Marchetti, 2023, Frontiers in Oncology.

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

S. Barni, L. Cavanna, L. Boni, 2015, PloS one.

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

S. Barni, L. Cavanna, L. Boni, 2015, PloS one.

Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival.

A. Gasbarrini, M. Zoli, F. Piscaglia, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

A. Gasbarrini, F. Piscaglia, V. Santi, 2023, JHEP reports : innovation in hepatology.

Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer Survivors

M. Dieci, G. Caprara, A. Fabi, 2021, Frontiers in Oncology.

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

A. Gasbarrini, M. Zoli, F. Piscaglia, 2017, Alimentary pharmacology & therapeutics.

Years of life that could be saved from prevention of hepatocellular carcinoma

A. Gasbarrini, M. Bernardi, M. Zoli, 2016, Alimentary pharmacology & therapeutics.